BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1846329)

  • 1. Asbestos fibres inhibit the in vitro activity of lymphokine-activated killer (LAK) cells from healthy individuals and patients with malignant mesothelioma.
    Manning LS; Davis MR; Robinson BW
    Clin Exp Immunol; 1991 Jan; 83(1):85-91. PubMed ID: 1846329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indomethacin augments lymphokine-activated killer cell generation by patients with malignant mesothelioma.
    Manning LS; Bowman RV; Davis MR; Musk AW; Robinson BW
    Clin Immunol Immunopathol; 1989 Oct; 53(1):68-77. PubMed ID: 2788546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysis of human malignant mesothelioma cells by natural killer (NK) and lymphokine-activated killer (LAK) cells.
    Manning LS; Bowman RV; Darby SB; Robinson BW
    Am Rev Respir Dis; 1989 Jun; 139(6):1369-74. PubMed ID: 2786360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capacity of tumor necrosis factor to augment lymphocyte-mediated tumor cell lysis of malignant mesothelioma.
    Bowman RV; Manning LS; Davis MR; Robinson BW
    Clin Immunol Immunopathol; 1991 Jan; 58(1):80-91. PubMed ID: 1983971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo boosting of lung natural killer and lymphokine-activated killer cell activity by interleukin-2: comparison of systemic, intrapleural and inhalation routes.
    Flexman JP; Manning LS; Robinson BW
    Clin Exp Immunol; 1990 Oct; 82(1):151-6. PubMed ID: 2208789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asbestos in the lungs of persons exposed in the USA.
    Langer AM; Nolan RP
    Monaldi Arch Chest Dis; 1998 Apr; 53(2):168-80. PubMed ID: 9689804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LAK-cell-mediated cytotoxicity against tumor cell targets used to monitor the stimulatory effect of interleukin-2: cytotoxicity, target recognition and phenotype of effector cells lysing the Daudi, T24 and K562 tumor cell lines.
    Hermann GG; Zeuthen J; Claësson MH
    Nat Immun; 1992; 11(1):7-16. PubMed ID: 1611282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent data on cancer due to asbestos in the U.S.A. and Denmark.
    Nicholson WJ; Raffn E
    Med Lav; 1995; 86(5):393-410. PubMed ID: 8684290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin formation inhibits the in vitro cytotoxic activity of human natural and lymphokine-activated killer cells.
    Gunji Y; Lewis J; Gorelik E
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):663-72. PubMed ID: 2133246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human lymphokine-activated killer cells are cytotoxic against cells infected with Toxoplasma gondii.
    Subauste CS; Dawson L; Remington JS
    J Exp Med; 1992 Dec; 176(6):1511-9. PubMed ID: 1460415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment in cytotoxicity and expression of NK cell- activating receptors on human NK cells following exposure to asbestos fibers.
    Nishimura Y; Miura Y; Maeda M; Kumagai N; Murakami S; Hayashi H; Fukuoka K; Nakano T; Otsuki T
    Int J Immunopathol Pharmacol; 2009; 22(3):579-90. PubMed ID: 19822075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation stimulating effects of chrysotile and crocidolite asbestos fibres on B lymphocyte cell lines.
    Ueki A; Oka T; Mochizuki Y
    Clin Exp Immunol; 1984 May; 56(2):425-30. PubMed ID: 6329565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of asbestos on the random migration of rabbit alveolar macrophages.
    Myrvik QN; Knox EA; Gordon M; Shirley PS
    Environ Health Perspect; 1985 May; 60():387-93. PubMed ID: 2863136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asbestos and cancer: human natural killer cell activity is suppressed by asbestos fibers but can be restored by recombinant interleukin-2.
    Robinson BW
    Am Rev Respir Dis; 1989 Apr; 139(4):897-901. PubMed ID: 2784645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance of chronic lymphocytic leukaemia cells to interferon-alpha generated lymphokine activated killer cells.
    Jewell AP; Worman CP; Giles FJ; Goldstone AH; Lydyard PM
    Leuk Lymphoma; 1992 Aug; 7(5-6):473-80. PubMed ID: 1362916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deposition and retention of inhaled fibres: effects on incidence of lung cancer and mesothelioma.
    Lippmann M
    Occup Environ Med; 1994 Dec; 51(12):793-8. PubMed ID: 7849861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Airborne fibre concentrations and lung burden compared to the tumour response in rats and humans exposed to asbestos.
    Rödelsperger K; Woitowitz HJ
    Ann Occup Hyg; 1995 Oct; 39(5):715-25. PubMed ID: 8526402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic action of a plant rhamnogalacturonan enhancing antitumor cytotoxicity of human natural killer and lymphokine-activated killer cells: chemical specificity of target cell recognition.
    Mueller EA; Anderer FA
    Cancer Res; 1990 Jun; 50(12):3646-51. PubMed ID: 1692765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of human NK cells and generation of LAK activity.
    Whiteside TL
    Curr Protoc Immunol; 2001 May; Chapter 7():Unit 7.7. PubMed ID: 18432847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.